Cargando…

Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease

The hallmarks of Alzheimer’s disease (AD) pathology are senile plaques containing amyloid-beta (Aβ) and neurofibrillary tangles containing hyperphosphorylated tau. Additional pathologies often co-exist, whereas multiple pathogenic mechanisms are involved in AD, especially synaptic degeneration, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eren, Erden, Leoutsakos, Jeannie-Marie, Troncoso, Juan, Lyketsos, Constantine G., Oh, Esther S., Kapogiannis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834433/ https://www.ncbi.nlm.nih.gov/pubmed/35159246 http://dx.doi.org/10.3390/cells11030436

Ejemplares similares

Comparative assessment of Alzheimer’s disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study
por: Manolopoulos, Apostolos, et al.
Publicado: (2023)

Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers
por: Wise, Elizabeth A., et al.
Publicado: (2019)

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline
por: Hochstetler, Helen, et al.
Publicado: (2015)

Extracellular vesicle biomarkers of Alzheimer's disease associated with sub‐clinical cognitive decline in late middle age
por: Eren, Erden, et al.
Publicado: (2020)

Weight Change and Neuropsychiatric Symptoms in Alzheimer’s Disease and Frontotemporal Dementia: Associations with Cognitive Decline
por: Morrow, Christopher B., et al.
Publicado: (2023)

Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker
por: Oh, Esther S., et al.
Publicado: (2015)

Graphical methods for understanding changes in states: Understanding medication use pathways
por: Wise, Elizabeth A., et al.
Publicado: (2022)

Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
por: Yao, Pamela J., et al.
Publicado: (2021)

Mitochondrial Protrusions in Neuronal Cells
por: Yao, Pamela J., et al.
Publicado: (2020)

Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19
por: Vannorsdall, Tracy D., et al.
Publicado: (2022)

Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity
por: Nogueras-Ortiz, Carlos J., et al.
Publicado: (2020)

Excitatory Neurons Derived from Human-Induced Pluripotent Stem Cells Show Transcriptomic Differences in Alzheimer’s Patients from Controls
por: Sagar, Ram, et al.
Publicado: (2023)

Vestibular therapy to reduce falls in people with Alzheimer’s disease: study protocol for a pilot randomized controlled trial
por: Yesantharao, Lekha V., et al.
Publicado: (2022)

Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014)

Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

Editorial: Alzheimer's Disease and the Fornix
por: Oishi, Kenichi, et al.
Publicado: (2016)

Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes
por: Haaksma, Miriam L., et al.
Publicado: (2018)

Early detection of cognitive decline in Alzheimer’s disease using eye tracking
por: Tokushige, Shin-ichi, et al.
Publicado: (2023)

Is your article EV-TRACKed?
por: Van Deun, Jan, et al.
Publicado: (2017)

Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease
por: Willette, Auriel A., et al.
Publicado: (2015)

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
por: Langbaum, Jessica B., et al.
Publicado: (2020)

Alzheimer's disease severity, objectively determined and measured
por: Gross, Alden L., et al.
Publicado: (2016)

Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease
por: Delgado-Peraza, Francheska, et al.
Publicado: (2021)

Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
por: Yu, Xianfeng, et al.
Publicado: (2023)

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

The Relationship between Neuropsychiatric Symptoms and Cognitive Performance in Older Adults with Normal Cognition
por: Liampas, Ioannis, et al.
Publicado: (2022)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
por: Cullen, Nicholas C., et al.
Publicado: (2021)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer’s disease
por: Gao, Yurui, et al.
Publicado: (2020)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
por: Liampas, Ioannis, et al.
Publicado: (2022)

Periodontitis and Cognitive Decline in Alzheimer’s Disease
por: Ide, Mark, et al.
Publicado: (2016)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Cognitive Decline: Not Always Alzheimer’s Disease
por: Villalba, Noel Lorenzo, et al.
Publicado: (2018)

Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins
por: Avila, Jesús, et al.
Publicado: (2017)

Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer’s disease mutations
por: Keramidis, Iason, et al.
Publicado: (2023)

Alzheimer’s Disease-Related Genes Identified by Linking Spatial Patterns of Pathology and Gene Expression
por: Mullins, Roger, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lgs2c8f4obohq9e0pj50i1bi5b